Bcl-2 antagonist BDA-366, Purity ≥98%

Synonym: 1909226-00-1; 142645-19-0; BDA-366; BDA366; 1-[[(2S)-3-(Diethylamino)-2-hydroxypropyl]amino]-4-[[(2S)-2-oxiranylmethyl]amino]-9,10-anthracenedione; Bcl-2 antagonist

CAS Number: 142645-19-0
Compound CID: 91826545

Product Size

2 mg; 5 mg; 10 mg; 25 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

BDA-366 specifically inhibits the function of the anti-apoptotic proteins, thereby promoting apoptosis in cancer cells.

Molecular Weight

423.5

Molecular Formula

C₂₄H₂₉N₃O₄

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

BDA-366 can be used to modulate of Bcl-2 family proteins to assess cancer cell sensitivity.

Storage

Store at -20ºC.